HASSANEIN WALEED H

PrivateCIK: 1430466
Location

ANDOVER, MA

HASSANEIN WALEED H (President & CEO) sold 12.3% of their position (8.63K shares) of TRANSMEDICS GROUP, INC. on the open market

Open‑market sale worth $1.17M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderHASSANEIN WALEED HCIK 1430466
IssuerTRANSMEDICS GROUP, INC.CIK 1756262
DirectorOfficer· President & CEO
Since May 2019
-8.63K
Net shares
Net seller
$1.17M
Total sold
4
Open market trades
0B · 4S
6
Total transactions
8.63K acquired · 17.25K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+8.63K

Price / share

$13.28

Trade value

$114.54K

% of position

14.0%
5/15/2024
61.64K70.27K

Common Stock

Direct
S · Sale

Shares

300.00

Price / share

$133.42

Trade value

$40.03K

% of position

0.4%
5/15/2024
70.27K69.97K

Common Stock

Direct
S · Sale

Shares

2.10K

Price / share

$134.69

Trade value

$282.85K

% of position

3.0%
5/15/2024
69.97K67.87K

Common Stock

Direct
S · Sale

Shares

5.48K

Price / share

$135.54

Trade value

$742.89K

% of position

8.1%
5/15/2024
67.87K62.39K

Common Stock

Direct
S · Sale

Shares

744.00

Price / share

$136.26

Trade value

$101.38K

% of position

1.2%
5/15/2024
62.39K61.64K
Total

Net shares

+0.00

Net value

-$1.05M

Derivative Transactions1

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

8.63K shares

Shares

8.63K

Strike price

13.28

Held after

139.38K

Exercisable

5/15/2024
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned469.36K
Total
469.36K indirect469.36K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
HASSANEIN WALEED H — Insider Transaction (Form 4) Filed May 17, 2024 | Finecho